Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | PER2 | O15055 | 3/20 | 0.32 |
| ▸ | CRY1 | Q16526 | 3/20 | 0.32 |
| ▸ | CRY2 | Q49AN0 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1546414 | 0.77 | USP2 (0.45) | SMN1; SMN2MEN1KMT2A | |
| SCHEMBL4322770 | 0.77 | CYP1A2 (0.43) | CYP1A2MAPK1SMN1; SMN2HTR1AHTR7 | |
| SCHEMBL4326132 | 0.77 | CYP1A2 (0.48) | CYP1A2MAPK1SMN1; SMN2KMT2AGLA | |
| SCHEMBL3178949 | 0.76 | SMN1; SMN2 (0.44) | CYP1A2MAPK1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL13929146 | 0.73 | CXCR4 (0.41) | PER2CRY1CRY2SMN1; SMN2MEN1 | |
| Trifluoroacetic Acid SCHEMBL3363160 | 0.72 | PDK2 (0.33) | OPRM1SMN1; SMN2MEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL1546439 | 0.72 | PDK2 (0.33) | OPRM1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL15238803 | 0.71 | CYP1A2 (0.48) | PER2CRY1CRY2CYP1A2MAPK1 | |
| SCHEMBL2814302 | 0.71 | PER2 (0.37) | PER2CRY1CRY2 | |
| SCHEMBL21384227 | 0.70 | PER2 (0.33) | PER2CRY1CRY2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1996590-A1 | SPIROINDOLINONE DERIVATIVES | F. Hoffmann-la Roche AG (CH) | 2008-12-03 | — | — | EP | disclosed |
| EP-1960368-A1 | 2,4,5-TRIPHENYL IMIDAZOLINE DERIVATIVES AS INHIBITORS OF THE INTERACTION BETWEEN P53 AND MDM2 PROTEINS FOR USE AS ANTICANCER AGENTS | F. Hoffmann-la Roche AG (CH) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007104664-A1 | SPIROINDOLINONE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-09-20 | — | — | WO | disclosed |
| WO-2007063013-A1 | 2,4,5-TRIPHENYL IMIDAZOLINE DERIVATIVES AS INHIBITORS OF THE INTERACTION BETWEEN P53 AND MDM2 PROTEINS FOR USE AS ANTICANCER AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-06-07 | — | — | WO | disclosed |